Christopher Anzalone
2021
Compensation breakdown
| Non-Equity Incentive Plan | $845,000 |
|---|---|
| Salary | $837,031 |
| Stock Awards | $23,019,000 |
| Other | $2,824 |
| Total | $24,703,855 |
Anzalone received $23M in stock awards, accounting for 93% of the total pay in 2021.
Anzalone also received $845K in non-equity incentive plan, $837K in salary and $2.8K in other compensation.
Rankings
In 2021, Christopher Anzalone's compensation ranked 218th out of 12,415 executives tracked by ExecPay. In other words, Anzalone earned more than 98.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 218 out of 12,415 | 98th |
Division Manufacturing | 63 out of 5,505 | 99th |
Major group Chemicals And Allied Products | 20 out of 2,375 | 99th |
Industry group Drugs | 16 out of 2,096 | 99th |
Industry Pharmaceutical Preparations | 7 out of 1,546 | 100th |
Pay ratio
| Christopher Anzalone's Pay | $24,703,855 |
|---|---|
| Median Employee's Pay | $168,720 |
| Pay Ratio | 146to 1 |
In 2021, the annual total compensation of Christopher Anzalone was $24,703,855.
The annual total compensation of the median employee at Arrowhead Research was $168,720.
The ratio of Christopher Anzalone's pay to the pay of median employee was therefore 146 to one.
Anzalone's colleagues
We found five more compensation records of executives who worked with Christopher Anzalone at Arrowhead Research in 2021.
2021
Patrick O'Brien
Arrowhead Research
General Counsel
2021
Kenneth Myszkowski
Arrowhead Research
Chief Financial Officer
2021
James Hamilton
Arrowhead Research
Sr. VP Discovery and
2021
James Hassard
Arrowhead Research
Chief Commercial Officer
2021
Javier San Martin
Arrowhead Research
Chief Medical Officer
News
January 26, 2022
January 27, 2021
January 28, 2020
January 25, 2019